Histological analyses revealed that either SRSF10 deficiency or SR3029 treatment reduced tumor cell density, and the combination of SRSF10 deficiency and SR3029 treatment exerted strongest inhibitory effect on tumor cell density (Fig. 10H). The gene discussed is SRSF10; the disease is neoplasm.